as part of a health survey carried out in alberta , canada , 2,609 subjects completed a standardized respiratory symptom questionnaire and had fev1 measured before and 20 min after inhaling terbutaline sulfate via a 750-ml spacer device .
C0001914
alberta
C0006823
canada